Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | LEGN Legend Biotech Corporation | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $19.11 +0.3% | $14.86 -2.5% |
| StockIQ Score | 32F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 32F | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 32F | 50C- |
| Quality | — | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Legend Biotech (LEGN) outperforms Ascentage Pharma (AAPG) in investor confidence and technical strength, scoring 50 versus 37 in investor trust and 46 versus 18 technically. AAPG leads in growth potential with a score of 50, while LEGN’s fundamental, valuation, and growth data are unavailable. Overall, LEGN shows stronger stability metrics, while AAPG excels in growth.
